肝硬化患者门静脉压力随临床改善而自发降低。 - Suppr

Suppr

超能文献

Spontaneous decrease in portal pressure with clinical improvement in cirrhosis.

作者信息

REYNOLDS T B, GELLER H M, KUZMA O T, REDEKER A G

出版信息

N Engl J Med. 1960 Oct 13;263:734-9. doi: 10.1056/NEJM196010132631505.

DOI:10.1056/NEJM196010132631505

PMID:13741112

Abstract

摘要

相似文献

Spontaneous decrease in portal pressure with clinical improvement in cirrhosis.

N Engl J Med. 1960 Oct 13;263:734-9. doi: 10.1056/NEJM196010132631505.

[The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension].

Klin Med (Mosk). 2007;85(8):15-9.

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.

Gastroenterology. 2009 May;136(5):1651-8. doi: 10.1053/j.gastro.2009.01.043. Epub 2009 Jan 24.

[Portal hypertension in cirrhoses: mechanisms, symptomatology and complications].

Rev Prat. 1990 Jun 1;40(16):1454-7.

[Fluctuations of portal pressure under normal conditions and evaluation of the severity of portal hypertension in liver cirrhosis].

Ter Arkh. 1971 Jul;43(6):65-9.

[Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis].

Eksp Klin Gastroenterol. 2009(5):130-7.

[Prognosis of portal hypertension in hepatitic cirrhosis of the liver (author's transl)].

Dtsch Med Wochenschr. 1981 Jul 31;106(31-32):990-3. doi: 10.1055/s-2008-1070440.

Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.

Hepatology. 1999 Feb;29(2):334-9. doi: 10.1002/hep.510290203.

[Pulmonary arterial hypertension complicating portal hypertension and liver biliary cirrhosis--a case report].

Kardiol Pol. 2006 Feb;64(2):193-7.

[Decrease of insulin resistance after splenectomy in a diabetic patient with liver cirrhosis and portal hypertension. Physiopathologic evaluation].

Minerva Gastroenterol Dietol. 1994 Dec;40(4):213-8.

引用本文的文献

Future therapy of portal hypertension in liver cirrhosis - a guess.

F1000Prime Rep. 2014 Oct 1;6:95. doi: 10.12703/P6-95. eCollection 2014.

The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.

PLoS One. 2014 Jul 28;9(7):e103779. doi: 10.1371/journal.pone.0103779. eCollection 2014.

Pathogenesis and management of alcoholic liver cirrhosis: a review.

Hepat Med. 2011 Dec 24;3:1-11. doi: 10.2147/HMER.S10265.

Long-term effectiveness of high-dosed ornithine-aspartate on urea synthesis rate and portal hypertension in human liver cirrhosis.

Amino Acids. 1992 Jun;3(2):147-53. doi: 10.1007/BF00806780.

A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm.

Int J Hepatol. 2011;2011:801983. doi: 10.4061/2011/801983. Epub 2011 Oct 26.

Treatment of decompensated alcoholic liver disease.

Int J Hepatol. 2011;2011:219238. doi: 10.4061/2011/219238. Epub 2011 Jul 12.

Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence.

Gut. 2004 Jan;53(1):143-8. doi: 10.1136/gut.53.1.143.

Treatment of Ascites.

Curr Treat Options Gastroenterol. 2003 Dec;6(6):481-491. doi: 10.1007/s11938-003-0050-5.

OBSERVATIONS ON INTRAHEPATIC VASCULAR PRESSURE REGULATION IN PORTAL HYPERTENSION.

Ann Surg. 1963 Jul;158(1):109-16. doi: 10.1097/00000658-196307000-00020.

Long-term medical management and complications of 'resistant' ascites.

Gut. 1961 Dec;2(4):285-96. doi: 10.1136/gut.2.4.285.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验